Peer Review History
| Original SubmissionSeptember 9, 2020 |
|---|
|
PONE-D-20-28422 Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson's Disease: A feasibility study PLOS ONE Dear Dr. Freidle, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Imre Cikajlo, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.Thank you for including your ethics statement: "Written consent given by the regional Research Ethics Board, Stockholm. 2016/1264-31/4 with amendments". Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. 3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 4.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Additional Editor Comments: Please review the manuscript according to the reviewers' suggestions. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: PLOS one review This study was a nice feasibility study that looked at implicit versus explicit motor learning in people with Parkinson’s Disease. To determine the influence of cognitive demands on motor learning, the authors included a dual task to a common key-press experiment. The study was intended to confirm the feasibility of using the task inside an fMRI machine. The authors have promoted transparency by providing their data and analysis, and used descriptive statistics to draw inferences because their study was admittedly underpowered. I think this is a great feasibility study, and I think more studies like this should be published. I just have minor suggestions for clarity before publication. Also please note there are some grammatical errors throughout the manuscript that should be addressed by an editor and this reviewer will ignore. Line 37: RT hasn’t been previously defined Line 47: Are you referring to deficits in motor learning and dual-tasking specific to PD? Please clarify. There is a modern meta-analysis that you could cite in your intro: Raffegeau, T.E., Krehbiel, L.M., Kang, N., Thijs, F.J., Altmann, L.J.P., Cauraugh, J.H., Hass, C.J., 2019. A meta-analysis: Parkinson’s disease and dual-task walking. Park. Relat. Disord. 62, 28–35. https://doi.org/10.1016/j.parkreldis.2018.12.012 Line 50: The following sentence is vague, please clarify that you are referring to people with PD. Line 52: Please clarify what you mean when you say walking consists of a ‘series of complicated movements’. Adding a sentence or two would help clarify the rationale of the experiment. I believe the argument could be that movement becomes less automatic with PD and thus could cause interference in motor learning mediated by cognitive processes. Line 79-83: Please clarify briefly that fMRI imposes limitations on cognitive test administration that this study is designed to overcome. A novice reader may be lost without a brief review of the fact that the key task has to be administered in an isolated way without the participant moving, etc. Line 101-102: Add medication state information to the Participants section 2.2. Please add if you controlled the study such that your testing time was during optimal medication states, i.e. 1-2 hours after taking their medication? I cant quite tell by the figure but I believe by the description of the task is that the keys are button-press keys. This may seem quite minor, but this reviewer is curious is the keys were rigid enough such that the commonly reported hand tremors wouldn’t influence performance for a PD patient? How much force is required to register a result? Later, there is good detail about how they examined key presses and excluded what appeared to be random responses, my guess is that if the key were too easy to press, that a tremor could be registered as a response.. A major strength of this design would be therefor the capability to prevent random key presses that are the result of bradykinesia or dyskinesia. For instance, a ‘touch pad’ key that doesn’t incorporate any haptic feedback may not be a good idea because it would pick up many more false positives. This may be worth mentioning in the Methods and Discussion. Later, given the interest in task fatigue, I found myself curious as to how long the protocol took and how long the break was, but I don’t see that information? Maybe I missed it, but highlighting that would help interpret your results. Line 212: Starting this sentence with a letter and numbers is confusing, adding the word ‘R software’ to this sentence would help. The section 2.5 is a nice detailing of the goals of the study. The Results are pretty hard to follow as is, but this numbering system helps. Can the authors please incorporate this numbering system to section 3.3? It might be nice to have a section 2.4.1 for SRRT descriptives and 2.4.2 for dual task descriptives, that would help the reader follow the corresponding Results in section 3.1 and 3.2. If you have enough room it would be nice to have a table or figure that presents the survey results, rather than reading through a long section. A suggestion for all figures, which do a nice job of showing individual data points. I suggest you use the ‘jitter’ function in whatever program you are using so that your data points re randomly distributed rather than displayed in ‘rows’ Line 394-396: I agree with this point and I think also that the rate of learning would be an interesting outcome for your paradigm. Perhaps moving away from magnitude based hypothesis testing to testing the slope of the change would be best, especially in complicated clinical samples. Line 407-409: While I agree your counting task likely leads to sufficient cognitive demand for a feasibility study, you could more carefully load ‘cognitive processes’ rather than simply dividing attention by adding some sort of inhibition/switching component to the task, which would greater challenge cognitive control/executive functions. While the counting task does load simple cognitive processes, your results could be more robust to PD-related deficits if you incorporated broader networks of cognitive processing. For instance, changing the color of the crosses periodically and instructing participants to only count Red crosses. Or changing the shape of the symbol and asking them only to count the star shapes. Etc. Adding another level of cognitive demand to your task would serve to strengthen the impact of your results long term. Line 426: I am glad you bring up the Response pad. Please see my thoughts above regarding the keys characteristics and add some information about that into this paragraph. Given your conclusions, is perhaps a solution to avoid spending too much time on simple RT tasks that might lead to fatigue down the road? To prevent fatigue, perhaps the majority of trials should be focused on dual tasks that disrupt cognitive processes the most? Especially for an fMRI response? Perhaps not. Could you please comment on that? Please comment on the implications of your study specifically for using in an fMRI study as well. Reviewer #2: The tasks should be presented and described in Methods/Procedure subchapter instead in Introduction. Why had healthy controls a higher MoCA threshold for the enrolment in the study? The explanation should be given for this different cognitive threshold. This patient and on healthy subject, with MoCA score <21, should not be included, rather then be excluded. Table 1. The t-test should be performed and p values given for possible difference in age, education or MoCA score, between patients and controls. Why was it necessary to remind subject of dual task approaching? At the beginning of last paragraph od chapter 2.3 the authors should give an explanation why exactly were participants given the questionnaire on whether they thought the trials in the SRTT followed a pattern? The manuscript needs thorough English grammar & language editing. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Tiphanie E Raffegeau Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson's Disease: A feasibility study PONE-D-20-28422R1 Dear Dr. Freidle, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Imre Cikajlo, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have done a nice job incorporating the reviewer's comments. After another round of grammar-checking and editing and this paper will make a nice addition to the literature. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Tiphanie E Raffegeau |
| Formally Accepted |
|
PONE-D-20-28422R1 Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson´s disease: A feasibility study Dear Dr. Freidle: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Imre Cikajlo Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .